Potential of long non-coding RNAs as a therapeutic target and molecular markers in glioblastoma pathogenesis

Area of Science:

• Oncology
• Genetics
• Epigenetics

Background:

• Glioblastoma (GB) is an aggressive brain tumor with limited treatment options and few diagnostic markers.
• Long non-coding RNAs (lncRNAs), once considered non-functional, are now recognized as key epigenetic regulators in tumorigenesis.
• The exact role of dysregulated lncRNAs in glioblastoma pathogenesis requires further elucidation.

Purpose of the Study:

• To review current findings on lncRNAs in glioblastoma research.
• To summarize the roles and classifications of lncRNAs in glioblastoma.
• To emphasize the prognostic and therapeutic potential of lncRNAs in glioblastoma.

Main Methods:

• Literature review of existing research on lncRNAs and glioblastoma.
• Analysis of high-throughput sequencing data to identify lncRNA profiles.
• Classification of lncRNAs based on their roles in glioblastoma.

Main Results:

• lncRNAs play significant roles in the initiation and progression of glioblastoma.
• Dysregulated lncRNAs are increasingly identified as potential diagnostic and prognostic biomarkers.
• lncRNAs demonstrate considerable promise as therapeutic targets for glioblastoma.

Conclusions:

• lncRNAs are vital epigenetic regulators with significant implications in glioblastoma.
• Further research into lncRNA mechanisms can unlock new diagnostic and therapeutic strategies for glioblastoma.
• lncRNAs represent a promising frontier for advancing glioblastoma treatment and patient outcomes.